These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 1338040

  • 1. The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake.
    Drejer K.
    Diabetes Metab Rev; 1992 Oct; 8(3):259-85. PubMed ID: 1338040
    [No Abstract] [Full Text] [Related]

  • 2. Insulin and IGF-I analogs: novel approaches to improved insulin pharmacokinetics.
    Slieker LJ, Brooke GS, Chance RE, Fan L, Hoffmann JA, Howey DC, Long HB, Mayer J, Shields JE, Sundell KL.
    Adv Exp Med Biol; 1993 Oct; 343():25-32. PubMed ID: 8184740
    [No Abstract] [Full Text] [Related]

  • 3. Recombinant canine single chain insulin analogues: insulin receptor binding capacity and ability to stimulate glucose uptake.
    Adams JP, Holder AL, Catchpole B.
    Vet J; 2014 Dec; 202(3):436-42. PubMed ID: 25457265
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo potency of insulin analogues designed for clinical use.
    Vølund A, Brange J, Drejer K, Jensen I, Markussen J, Ribel U, Sørensen AR, Schlichtkrull J.
    Diabet Med; 1991 Nov; 8(9):839-47. PubMed ID: 1663018
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Insulin-like compounds related to the amphioxus insulin-like peptide.
    Chu YC, Hu SQ, Zong L, Burke GT, Gammeltoft S, Chan SJ, Steiner DF, Katsoyannis PG.
    Biochemistry; 1994 Sep 20; 33(37):11278-85. PubMed ID: 7727378
    [Abstract] [Full Text] [Related]

  • 10. The insulin-like growth factor-I receptor. Structure, ligand-binding mechanism and signal transduction.
    De Meyts P, Wallach B, Christoffersen CT, Ursø B, Grønskov K, Latus LJ, Yakushiji F, Ilondo MM, Shymko RM.
    Horm Res; 1994 Sep 20; 42(4-5):152-69. PubMed ID: 7868068
    [Abstract] [Full Text] [Related]

  • 11. Correlation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide.
    Stagsted J, Hansen T, Roth RA, Goldstein A, Olsson L.
    J Pharmacol Exp Ther; 1993 Nov 20; 267(2):997-1001. PubMed ID: 8246175
    [Abstract] [Full Text] [Related]

  • 12. Insulin-receptor kinase is enhanced in placentas from non-insulin-dependent diabetic women with large-for-gestational-age babies.
    Takayama-Hasumi S, Yoshino H, Shimisu M, Minei S, Sanaka M, Omori Y.
    Diabetes Res Clin Pract; 1994 Jan 20; 22(2-3):107-16. PubMed ID: 8200291
    [Abstract] [Full Text] [Related]

  • 13. Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities.
    Bornfeldt KE, Gidlöf RA, Wasteson A, Lake M, Skottner A, Arnqvist HJ.
    Diabetologia; 1991 May 20; 34(5):307-13. PubMed ID: 1713869
    [Abstract] [Full Text] [Related]

  • 14. Analysis of the receptor complement for insulin and insulin-like growth factor I (IGF-I) in the rat visceral yolk sac.
    Cowley E, Pratten M.
    Biochem Soc Trans; 1992 Aug 20; 20(3):280S. PubMed ID: 1426565
    [No Abstract] [Full Text] [Related]

  • 15. Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity.
    Ebina Y, Araki E, Taira M, Shimada F, Mori M, Craik CS, Siddle K, Pierce SB, Roth RA, Rutter WJ.
    Proc Natl Acad Sci U S A; 1987 Feb 20; 84(3):704-8. PubMed ID: 3101064
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibodies as probes of the structure and function of insulin receptors.
    Siddle K, Soos MA, O'Brien RM, Ganderton RH, Taylor R.
    Biochem Soc Trans; 1987 Feb 20; 15(1):47-51. PubMed ID: 3549387
    [No Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation.
    Yau L, Lukes H, McDiarmid H, Werner J, Zahradka P.
    Eur J Biochem; 1999 Dec 20; 266(3):1147-57. PubMed ID: 10583412
    [Abstract] [Full Text] [Related]

  • 18. In vitro evolution of amphioxus insulin-like peptide to mammalian insulin.
    Guo ZY, Shen L, Gu W, Wu AZ, Ma JG, Feng YM.
    Biochemistry; 2002 Aug 27; 41(34):10603-7. PubMed ID: 12186544
    [Abstract] [Full Text] [Related]

  • 19. The (ProB27, ThrB28) human insulin analogue is more potent and more rapidly absorbed from subcutis than human insulin.
    Clausen R, Jørgensen TG, Jørgensen KH, Johnsen AH, Led JJ, Josefsen K.
    Eur J Endocrinol; 2002 Aug 27; 147(2):227-33. PubMed ID: 12153745
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of IGF-I-stimulated glucose transport in human adipocytes. Demonstration of specific IGF-I receptors not involved in stimulation of glucose transport.
    Sinha MK, Buchanan C, Leggett N, Martin L, Khazanie PG, Dimarchi R, Pories WJ, Caro JF.
    Diabetes; 1989 Oct 27; 38(10):1217-25. PubMed ID: 2551760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.